| 7794725 |
Isolated peptides derived from human immunodeficiency virus types 1 and 2 containing fusion inhibitory domains |
Dennis Michael Lambert, Stephen Robert Petteway |
2010-09-14 |
$334,000 |
| 7514397 |
Methods for inhibition of membrane-fusion-associated events, including Hepatitis B virus transmission |
Dennis Michael Lambert, Stephen Robert Petteway |
2009-04-07 |
$983,000 |
| 7297784 |
DNA encoding T-1249 and other viral fusion inhibitor peptides useful for treating aids |
Kelly I. Guthrie, Gene Merutka, Mohmed K. Anwer, Dennis Michael Lambert |
2007-11-20 |
$1,750,000 |
| 7122190 |
Fusion proteins comprising DP-178 and other viral fusion inhibitor peptides useful for treating aids |
Dani P. Bolognesi, Thomas James Matthews, Carl T. Wild, Dennis Michael Lambert, Stephen Robert Petteway +1 more |
2006-10-17 |
|
| 6951717 |
Methods and compositions for inhibition of membrane fusion-associated events, including HIV transmission |
Dennis Michael Lambert, Stephen Robert Petteway |
2005-10-04 |
$3,046,000 |
| 6656906 |
Hybrid polypeptides with enhanced pharmacokinetic properties |
Kelly I. Guthrie, Gene Merutka, Mohmed K. Anwer, Dennis Michael Lambert |
2003-12-02 |
$4,901,000 |
| 6562787 |
Hybrid polypeptides with enhanced pharmacokinetic properties |
Kelly I. Guthrie, Gene Merutka, Mohmed K. Anwer, Dennis Michael Lambert |
2003-05-13 |
$10,079,000 |
| 6518013 |
Methods for the inhibition of epstein-barr virus transmission employing anti-viral peptides capable of abrogating viral fusion and transmission |
Dennis Michael Lambert, Stephen Robert Petteway |
2003-02-11 |
$10,620,000 |
| 6479055 |
Methods for inhibition of membrane fusion-associated events, including respiratory syncytial virus transmission |
Dani P. Bolognesi, Thomas James Matthews, Carl T. Wild, Dennis Michael Lambert, Stephen Robert Petteway +1 more |
2002-11-12 |
$11,495,000 |
| 6440656 |
Methods for the inhibition of respiratory syncytial virus transmission |
Dani P. Bolognesi, Thomas James Matthews, Carl T. Wild, Dennis Michael Lambert, Stephen Robert Petteway |
2002-08-27 |
$12,148,000 |
| 6348568 |
Hybrid polypeptides with enhanced pharmacokinetic properties |
Kelly I. Guthrie, Gene Merutka, Mohmed K. Anwer, Dennis Michael Lambert |
2002-02-19 |
$9,053,000 |
| 6333395 |
Compositions for inhibition of membrane fusion-associated events, including human parainfluenza virus transmission |
Dennis Michael Lambert, Stephen Robert Petteway |
2001-12-25 |
|
| 6277974 |
Compositions and methods for diagnosing and treating conditions, disorders, or diseases involving cell death |
Donald C. Lo, Mary Beth Thomas, Stuart Portbury, Kasturi Puranam, Lawrence C. Katz |
2001-08-21 |
|
| 6258782 |
Hybrid polypeptides with enhanced pharmacokinetic properties |
Kelly I. Guthrie, Gene Merutka, Mohmed K. Anwer, Dennis Michael Lambert |
2001-07-10 |
$11,309,000 |
| 6228983 |
Human respiratory syncytial virus peptides with antifusogenic and antiviral activities |
Dennis Michael Lambert, Stephen Robert Petteway |
2001-05-08 |
$10,105,000 |
| 6093794 |
Isolated peptides derived from the Epstein-Barr virus containing fusion inhibitory domains |
Dennis Michael Lambert, Stephen Robert Petteway |
2000-07-25 |
$22,120,000 |
| 6068973 |
Methods for inhibition of membrane fusion-associated events, including influenza virus |
Dennis Michael Lambert, Stephen Robert Petteway |
2000-05-30 |
$14,837,000 |
| 6060065 |
Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission |
Dennis Michael Lambert, Stephen Robert Petteway |
2000-05-09 |
$13,476,000 |
| 6054265 |
Screening assays for compounds that inhibit membrane fusion-associated events |
Dennis Michael Lambert, Stephen Robert Petteway |
2000-04-25 |
$12,048,000 |
| 6017536 |
Simian immunodeficiency virus peptides with antifusogenic and antiviral activities |
Dennis Michael Lambert, Stephen Robert Petteway, Alphonse J. Langlois |
2000-01-25 |
$13,032,000 |
| 6013263 |
Measles virus peptides with antifusogenic and antiviral activities |
Dennis Michael Lambert, Stephen Robert Petteway |
2000-01-11 |
$10,132,000 |